RecruitingPhase 3NCT07797335
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Sponsor: Novo Nordisk A/S
Bountiful, UT · Layton, UT · Salt Lake City, UT · +106 more sites